Literature DB >> 9545319

Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart.

L Vittone1, C Mundiña-Weilenmann, M Said, A Mattiazzi.   

Abstract

Previous experiments have shown that acidosis enhances isoproterenol-induced phospholamban (PHL) phosphorylation (Mundiña-Weilenmann, C., Vittone, L., Cingolani, H. E., Orchard, C. H. (1996) Am. J. Physiol. 270, C107-C114). In the present experiments, performed in isolated Langendorff perfused rat hearts, phosphorylation site-specific antibodies to PHL combined with the quantitative measurement of 32P incorporation into PHL were used as experimental tools to gain further insight into the mechanism involved in this effect. At all isoproterenol concentrations tested (3-300 nM), phosphorylation of Thr17 of PHL was significantly higher at pHo 6.80 than at pHo 7.40, without significant changes in Ser16 phosphorylation. This increase in Thr17 phosphorylation was associated with an enhancement of the isoproterenol-induced relaxant effect. In the absence of isoproterenol, the increase in [Ca]o at pHo 6.80 (but not at pHo 7.40) evoked an increase in PHL phosphorylation that was exclusively due to an increase in Thr17 phosphorylation and that was also associated with a significant relaxant effect. This effect and the phosphorylation of Thr17 evoked by acidosis were both offset by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62. In the presence of isoproterenol, either the increase in [Ca]o or the addition of a 1 microM concentration of the phosphatase inhibitor okadaic acid was able to mimic the increase in isoproterenol-induced Thr17 phosphorylation produced by acidosis. In contrast, these two interventions have opposite effects on phosphorylation of Ser16. Whereas the increase in [Ca]o significantly decreased phosphorylation of Ser16, the addition of okadaic acid significantly increased the phosphorylation of this residue. The results are consistent with the hypothesis that the increase in phospholamban phosphorylation produced by acidosis in the presence of isoproterenol is the consequence of two different mechanisms triggered by acidosis: an increase in [Ca2+]i and an inhibition of phosphatases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545319     DOI: 10.1074/jbc.273.16.9804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation.

Authors:  Carlos A Valverde; Cecilia Mundiña-Weilenmann; Matilde Said; Paola Ferrero; Leticia Vittone; Margarita Salas; Julieta Palomeque; Martín Vila Petroff; Alicia Mattiazzi
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

2.  Accurate quantitation of phospholamban phosphorylation by immunoblot.

Authors:  Naa-Adjeley Ablorh; Tyler Miller; Florentin Nitu; Simon J Gruber; Christine Karim; David D Thomas
Journal:  Anal Biochem       Date:  2012-02-03       Impact factor: 3.365

3.  Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr(17) residue.

Authors:  A Mattiazzi; C Mundiña-Weilenmann; L Vittone; M Said
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

4.  Modeling the effects of β1-adrenergic receptor blockers and polymorphisms on cardiac myocyte Ca2+ handling.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Mol Pharmacol       Date:  2014-05-27       Impact factor: 4.436

5.  Effects of increased systolic Ca²⁺ and phospholamban phosphorylation during β-adrenergic stimulation on Ca²⁺ transient kinetics in cardiac myocytes.

Authors:  Steve R Roof; Thomas R Shannon; Paul M L Janssen; Mark T Ziolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-15       Impact factor: 4.733

6.  Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.

Authors:  Kristiina Rajamäki; Tommy Nordström; Katariina Nurmi; Karl E O Åkerman; Petri T Kovanen; Katariina Öörni; Kari K Eklund
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

7.  Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation.

Authors:  Naa-Adjeley Ablorh; Florentin Nitu; Kristin Engebretsen; David D Thomas; Joel S Holger
Journal:  Clin Toxicol (Phila)       Date:  2009-04       Impact factor: 4.467

8.  Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.

Authors:  Klara Brixius; Annette Wollmer; Birgit Bölck; Uwe Mehlhorn; Robert H G Schwinger
Journal:  Pflugers Arch       Date:  2003-10-03       Impact factor: 3.657

9.  Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.

Authors:  Hannes Hudalla; Zoe Michael; Nicolas Christodoulou; Gareth R Willis; Angeles Fernandez-Gonzalez; Evgenia J Filatava; Paul Dieffenbach; Laura E Fredenburgh; Robert S Stearman; Mark W Geraci; Stella Kourembanas; Helen Christou
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 7.748

Review 10.  The role of CaMKII regulation of phospholamban activity in heart disease.

Authors:  Alicia Mattiazzi; Evangelia G Kranias
Journal:  Front Pharmacol       Date:  2014-01-27       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.